| General Information | |||
|---|---|---|---|
| Term | hyperlipoproteinemia type III | ID (Ontology) | DOID:3145 (Human Disease) |
| Definition | A familial hyperlipidemia that has_material_basis_in by homozygous, compound heterozygous, or heterozygous mutation in the APOE gene on chromosome 19q13. | ||
| Also Known As | "carbohydrate induced hyperlipemia" ; "familial hypercholesterolaemia with hyperlipaemia" ; "familial type 3 hyperlipoproteinemia" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
No relevant statements available
|
|||
|
||||||
lipid metabolism disorder |__familial hyperlipidemia |__hyperlipoproteinemia type III |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | familial hyperlipidemia | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
MESH:D006952 MIM:617347 NCI:C34710 SNOMEDCT_US_2023_03_01:42569002 UMLS_CUI:C0020479 |
|||